Archive for July, 2014

Natural Complements to Conventional Dog Care


by Shawn Messonnier

Click the images below to view a clear and simple guide to which alternative remedies and lifestyle changes are appropriate for common canine medical conditions.Dog CareDog Care 2

New Tests Detect Early Cancer in Dogs

by Dr. Shawn Messonnier

There is now an accurate, inexpensive way way to allow the detection of cancer and other inflammatory diseases before a pet actually develop clinical signs of cancer. The blood panel tests provide early detection that allow intervention prior to disease progression, when greater damage occurs and options become more expensive and limited.

The tests measure several aspects of cell irregularity: abnormal cell division and systemic inflammatory activity. Thymidine kinase (TK) is a measure of dysregulated cellular proliferation; as cancer cells divide, TK is usually increased. C-reactive protein (CRP) is elevated in the presence of systemic inflammatory diseases, including cancer.

In a study group of 360 dogs followed for up to one year, incidence of cancer and serious disease were tracked. The study showed that almost 100 percent of cancers were detected four to six months prior to the pet showing symptoms. Designed to be part of a routine wellness plan, these cancer screening tests are the most comprehensive single blood test available in monitoring the overall health status of a dog.

In addition to screening for cancer, checking the vitamin D status of a dog is also important, because low levels of vitamin D have been shown to contribute to increased incidence of cancer and infectious diseases.

Dr. Shawn Messonnier is a holistic veterinarian in Plano, Texas, and founder of Dr. Shawn’s Naturals all-natural products and supplements for dogs. Natural Awakenings readers can save 10 percent on all in-stock products with the code DRSHAWN. For more information, visit


Natural Treatment Option for Respiratory Infections

According to the National Institutes of Health, lower respiratory infections are more prevalent worldwide than HIV, malaria, cancer and heart attacks. Those that suffer from chronic obstructive pulmonary disease, cystic fibrosis or asthma are especially prone reports the journal PLOS Medicine. Treatment can be especially difficult when it’s unclear if the cause is a virus, bacterium or fungus.

The typical Western practice of ingesting pills spreads drugs throughout the body instead of treating only the air-side of the lungs, where the problem is located. It’s better to target the active treatment agent only where it’s needed. A study in the European Journal of Clinical Micriobiology & Infectious Diseases suggests delivering a fine-droplet mist from a nebulizer directly atop the invading pathogens and replenishing often to keep the area moist with antimicrobials. This can achieve far greater local dosing with far lower systemic penetration. Choose an antimicrobial that kills all three potential types of pathogens so the physician won’t need to guess the proper drug or try them sequentially.

A more natural option is to avoid drugs. Clinical studies by the Klearsen Corporation and laboratory work at National Jewish Hospital have shown that locally administering an enhanced aqueous colloid of silver in the recommended manner will clear even the most stubborn pathogens. Plus, it has no adverse side effects.

When dosing with a liquid colloid of silver concentration of 50 parts per mission (ppm) or more, the suggested protocol is usually three milliliters, three times per day. For acute infections, the three-milliliter dose can be administered every two waking hours. Using a nebulizer is essential to achieve the effective micro-droplets required to reach all areas of the lungs. Inhaling the nebulized mist deep into the lungs will coat the invading pathogens. Note that a vaporizer isn’t suitable because its steam delivery will leave the active ingredients behind.

Steven Frank, has researched respiratory infection therapies for 15 years and holds three related patents. Study sites include the Institute for Tuberculosis Research, National Jewish Hospital and Klearsen Corporation. He presented Respiratory Clinical Trial results to the American Naturopathic Medical Association in 2006. He can be reached at

More Plastics, More Obese Kids

A causal link between the worldwide epidemic of childhood obesity and phthalates commonly used in soft plastics, packaging and many personal care products is becoming more evident. A Korean study from Sanggye Paik Hospital at the Inje University College of Medicine, in Seoul, shows that the risk of childhood obesity increases with the level of DEHP (di-2-ethylhexyl phthalate) in the bloodstream.

The study indicates that phthalates may change gene expression associated with fat metabolism. DEHP in particular is a suspected endocrine disruptor, or hormone-altering agent. Children with the highest DEHP levels were nearly five times more likely of being obese than children with the lowest levels. The scientists studied 204 children ages 6 to 13, of whom 105 were obese.

A chemical commonly used to soften plastics, DEHP is found in some children’s toys, as well as myriad household items. Phthalates can be found in pacifiers, plastic food packaging, medical equipment and building materials like vinyl flooring. Personal care products such as soap, shampoo and nail polish may also contain phthalates.

Star Trekking – Voyager 1 Enters Interstellar Space

The U.S. National Aeronautics and Space Agency (NASA) recently confirmed that after 36 years, the Voyager 1 probe crossed the boundary of the heliosphere, or the extent of our Sun’s influence, just over a year ago. It’s the first man-made object to venture into interstellar space.

At a distance of about 12 billion miles from the Sun, the latest data indicates that Voyager 1 has been traveling through the plasma, or ionized gas, present in the space between stars. The Journal Science notes that this corroborates the existence of a long-hypothesized boundary between the solar plasma and the interstellar plasma. Voyager 2, a companion craft launched at the same time, is also expected to break the barrier.